- Investing Ideas
- /
- Consumer Retailing Healthcare Sector
Consumer Retailing Healthcare Sector
Results
2305
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2305 companies
Bioxytran
Market Cap: US$14.1m
A clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans.
BIXT
US$0.15
7D
21.3%
1Y
14.2%
Psychemedics
Market Cap: US$14.1m
Engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally.
PMDI
US$2.30
7D
-2.5%
1Y
-10.5%
NKGen Biotech
Market Cap: US$14.0m
Operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies.
NKGN
US$0.29
7D
-17.2%
1Y
-79.6%
CareView Communications
Market Cap: US$14.0m
Operates as a video monitoring solutions provider in the United States.
CRVW
US$0.017
7D
-4.5%
1Y
-67.9%
NextCure
Market Cap: US$13.9m
A clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer.
NXTC
US$0.51
7D
15.9%
1Y
-67.2%
Lifeward
Market Cap: US$13.9m
A medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.
LFWD
US$1.26
7D
-3.1%
1Y
-73.3%
Trinity Biotech
Market Cap: US$13.7m
Acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe.
TRIB
US$0.69
7D
-18.2%
1Y
-59.0%
Rallybio
Market Cap: US$13.7m
A clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.
RLYB
US$0.33
7D
-5.9%
1Y
-78.9%
Ventripoint Diagnostics
Market Cap: CA$18.8m
A medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide.
VPT
CA$0.12
7D
-4.0%
1Y
-45.5%
EOM Pharmaceuticals Holdings
Market Cap: US$13.7m
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases.
IMUC
US$0.11
7D
-3.5%
1Y
-39.7%
Proteome Sciences
Market Cap: UK£10.1m
Provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally.
PRM
UK£0.034
7D
-7.8%
1Y
-0.6%
Portage Biotech
Market Cap: US$13.6m
A clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products.
PRTG
US$7.89
7D
0%
1Y
50.0%
PharmaTher Holdings
Market Cap: CA$18.6m
A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.
PHRM
CA$0.21
7D
2.4%
1Y
-4.5%
Biotricity
Market Cap: US$13.4m
A medical technology company, provides biometric data monitoring solutions in the United States.
BTCY
US$0.51
7D
5.9%
1Y
-57.1%
Cingulate
Market Cap: US$13.3m
A biopharmaceutical company, develops pharmaceutical products for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.
CING
US$3.66
7D
-4.2%
1Y
-61.3%
Lumos Diagnostics Holdings
Market Cap: AU$20.6m
Develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States and Australia.
LDX
AU$0.028
7D
1.9%
1Y
-23.6%
Unity Biotechnology
Market Cap: US$13.3m
A biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging.
UBX
US$0.78
7D
-5.0%
1Y
-47.4%
BiomX
Market Cap: US$13.2m
A clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic diseases.
PHGE
US$0.52
7D
-4.0%
1Y
-84.7%
Orgenesis
Market Cap: US$13.2m
A biotech company, focuses on cell and gene therapies worldwide.
ORGS
US$1.90
7D
-5.5%
1Y
-60.4%
Moleculin Biotech
Market Cap: US$13.2m
A clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and viruses.
MBRX
US$0.95
7D
1.2%
1Y
-80.7%
CardieX
Market Cap: AU$20.3m
Engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific.
CDX
AU$0.05
7D
-5.7%
1Y
-31.5%
iBio
Market Cap: US$13.1m
A preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases.
IBIO
US$0.82
7D
2.3%
1Y
-62.6%
ModivCare
Market Cap: US$13.1m
A technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and their members in the United States.
MODV
US$0.90
7D
-2.8%
1Y
-96.7%
Synlogic
Market Cap: US$13.0m
A biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States.
SYBX
US$1.13
7D
4.6%
1Y
-29.4%
BLIS Technologies
Market Cap: NZ$21.7m
Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity.
BLT
NZ$0.017
7D
21.4%
1Y
0%
Conavi Medical
Market Cap: CA$17.7m
Focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures.
CNVI
CA$0.40
7D
-4.8%
1Y
n/a
ProPhase Labs
Market Cap: US$12.9m
Develops and commercializes novel drugs, dietary supplements, and compounds in the United States.
PRPH
US$0.32
7D
-17.2%
1Y
-93.7%
Veri Medtech Holdings
Market Cap: US$12.8m
Provides health and wellness services and products through its healthcare technology platform.
VRHI
US$0.64
7D
-10.5%
1Y
105.8%
Inspira Technologies Oxy B.H.N
Market Cap: US$12.8m
A specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel.
IINN
US$0.47
7D
-6.7%
1Y
-78.3%
BriaCell Therapeutics
Market Cap: CA$17.5m
A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.
BCT
CA$4.23
7D
3.7%
1Y
-85.7%
CEL-SCI
Market Cap: US$12.6m
A clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States.
CVM
US$2.51
7D
-62.5%
1Y
-93.2%
Cell Source
Market Cap: US$12.6m
A biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance.
CLCS
US$0.28
7D
12.6%
1Y
n/a
OneMedNet
Market Cap: US$12.6m
A healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East.
ONMD
US$0.41
7D
-5.3%
1Y
-82.2%
Amplia Therapeutics
Market Cap: AU$19.4m
A clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia.
ATX
AU$0.05
7D
-23.1%
1Y
-23.1%
Zeo ScientifiX
Market Cap: US$12.5m
A clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines.
ZEOX
US$2.05
7D
-12.8%
1Y
103.0%
Noxopharm
Market Cap: AU$19.3m
A biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia.
NOX
AU$0.066
7D
-5.7%
1Y
-10.8%